THE DEAL, AT A GLANCE
From the announcementXellar Biosystems
01What it doesAt the core of Xellar's platform is a closed-loop system that combines human organ-on-chip models, automated experimentation, and computational intelligence.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Bessemer, model, ultimately predictFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedXellar Biosystems raised $50M Pre-Seed, announced 2026-06-30From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersXellar Biosystems' $50M pre-seed financing represents a mid-pack LegalTech round by tracked size despite being large in absolute early-stage capital terms, with the…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Xellar Biosystems · Financing Record
Explore source-linked visual explanations for Xellar Biosystems. Unsupported claims are withheld while source review continues.
Record 7033 · Recorded date: 2026-06-30
Explore company records →